Newton Biocapital
Venture capitalBrussels · Seed–Series A · 15 people tracked
Investment thesis
Newton Biocapital invests in life sciences innovation across Europe and Japan, leveraging strong ties to both regions' ecosystems to unlock cross-border opportunities and optimal exits through connections with local and international investors and pharma. The fund targets promising solutions for chronic health conditions with an aim to reduce patient and societal burdens. Drawing on the team's scientific and medical expertise plus a network of experts, the firm identifies opportunities across a range of technologies and disease areas, and participates actively as board members, supporting portfolio companies with their preclinical and clinical program selection to create value for patients, society, local ecosystems, and investors.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from the firm's website & public directories
What they invest in
from 11 of 16 portfolio companiesBiotech ×9Healthtech ×9Medical Devices ×7Deep Tech ×3Digital Health ×3AI & Machine Learning ×2
HQs:Belgium×5Japan×2European Union×1
Investments · 16 tracked
founders shown can be your intro pathAbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases.
BiotechHealthtech
Ignacio Anegon(Co-founder, Senior Consultant & SAB Member)Carole Guillonneau(Co-founder & Head of Research)François-Xavier Hubert(Co-founder, Past President & Board Member)
DeuterOncology is a clinical-stage biotech developing DO-2, a deuterated, brain-penetrant MET kinase and RAS pathway inhibitor for cancer patients, currently in a phase 1 clinical study.
BiotechHealthtechMedical DevicesLiege, BE
Dr Timothy PereraTimothy Perera(Founder & CEO)
Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders.
BiotechDeep TechHealthtechMedical Devices
Denis Bedoret(Executive Director)Benoit Vanhollebeke(Scientific Founder)
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.
BiotechHealthtechMedical DevicesGhent, BE
Dim3 provides medical device software and hardware for clinical nutrition management, helping doctors, dietitians, and nurses detect malnutrition risks, plan personalized nutrition interventions, and track patient outcomes in real-time across healthcare settings.
Digital HealthHealthtechMedical Devices
EPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.
BiotechDigital HealthMedical Devices
Santero is a Belgium-based biotech company developing antibacterial drugs, including an RSH inhibitor programme targeting Pseudomonas aeruginosa and multidrug-resistant pathogens.
AI & Machine LearningBiotechDeep TechHealthtechBrussels, BE
Abel Garcia-Pino(Co-founder & Scientific Advisor)Cédric Govaerts(Co-founder & Scientific Advisor)Mark Beards(Chief Executive Officer)Emilie Racine(COO & Head of Chemistry)Cuong Vuong(Chief Scientific Officer)Valérie Gallien(Chief of Staff)
Synergia Medical develops optoelectronic implantable medical devices, including its NAO.VNS vagus nerve stimulation system, which is undergoing First-In-Human clinical evaluation through the AURORA study.
Deep TechHealthtechMedical DevicesBrussels, BE
Charles Nolet(CEO)Vincent De Rudder(VP QARA)Gijs Klarenbeek(VP of Clinical)Dan Scherrer(COO)Dimitri Crelot(CFO)
Tensegrity is a pharmaceutical company focused on drug discovery and development, aiming to reduce R&D bottlenecks and bring new drugs to market.
BiotechHealthtech
EditForce develops proprietary PPR gene-editing technology that can modify both DNA and RNA, with applications in medicine, agriculture, and chemical industries.
AI & Machine LearningBiotech
J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases.
BiotechDigital HealthHealthtechMedical DevicesTokyo, JP
𠮷武 益広(代表取締役社長 (Representative Director & President))藤本 裕(取締役CFO)山本 寛(取締役CBO)
Frequently asked questions
- What stage does Newton Biocapital invest at?
- Newton Biocapital invests at the Seed, Series A stages.
- What sectors does Newton Biocapital focus on?
- Newton Biocapital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Newton Biocapital located?
- Newton Biocapital is headquartered in Brussels, BE.
- Does Newton Biocapital lead rounds?
- Yes, Newton Biocapital leads investment rounds.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital is an investment firm backing entrepreneurs building companies that address major global challenges and shape more sustainable, preferable futures.